| (210) | Number of the EPO application | 17854175 |
| (220) | Filing date of the EPO application | 2017.12.15 |
| (80) | EPO patent specification publication (B) | EPB nr. 24/2022, 2022.06.15 |
| (110) | EPO patent number | 3555097 |
| (11) | Number of the document | MD 3555097 T2 |
| (21) | Number of the application | e 2019 1212 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | KOUDRIAKOVA Tatiana, US;
KREUTTER Kevin D., US;
LEONARD Kristi, US;
RIZZOLIO Michele C., US;
SMITH Russell C., US;
TICHENOR Mark S., US;
WANG Aihua, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | Imidazo[4,5-d]pyrrolo[2,3-b]pyridine compounds as inhibitors of Janus kinases |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07D 471/14 (2006.01.01); A61K 31/437 (2006.01.01); A61P 29/00 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2019.12.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2022.12.31 |
| (30) | Priority | 201662435609 P, 2016.12.16, US; 201762592680 P, 2017.11.30, US; 201762596607 P, 2017.12.08, US |
| (74) | Patent attorney | (Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova |
| (86) | International application | PCT/US2017/066744, 2017.12.15 |
| (87) | International publication | WO 2018/112379, 2018.06.21 |